| abstract |
The present invention relates to a novel 4-phenyl-1,3-azole derivative having the following general formula (I): (This may be a racemate, an enantiomer, or any combination thereof, where R1, R2, R3, R4, X, A, B, and n are variable). Since these compounds show affinity for cannabinoid receptors, they can be used as drugs for treating or preventing pathological conditions and diseases involving at least one of these receptors. The invention also relates to pharmaceutical compositions comprising the product and their use to produce a drug. |